{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:36Z","timestamp":1707524076671},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,2]]},"DOI":"10.7759\/cureus.8972","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T23:33:00Z","timestamp":1593732780000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation"],"prefix":"10.7759","author":[{"given":"Quan D","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahita","family":"Tavana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"Saenz Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia E","family":"Posleman Monetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica S","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4921-9","article-title":"Male breast cancer: a disease distinct from female breast cancer","volume":"173","author":"Gucalp A","year":"2018","unstructured":"Gucalp A, Traina TA, Eisner JR, et al.. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat. 2018, 173:37-48. 10.1007\/s10549-018-4921-9","journal-title":"Breast Cancer Res Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/341943","article-title":"A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer","volume":"71","author":"Vahteristo P","year":"2002","unstructured":"Vahteristo P, Bartkova J, Eerola H, et al.. A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet. 2002, 71:432-438. 10.1086\/341943","journal-title":"Am J Hum Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2012.13.5.2051","article-title":"The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis","volume":"13","author":"Liu C","year":"2012","unstructured":"Liu C, Wang QS, Wang YJ. The CHEK2 I157T variant and colorectal cancer susceptibility: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2012, 13:2051-2055. 10.7314\/apjcp.2012.13.5.2051","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls","volume":"26","author":"Weischer M","year":"2008","unstructured":"Weischer M, Bojesen SE, Ellervik C, Tybj\u00e6rg-Hansen A, Nordestgaard BG. CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol. 2008, 26:542-548. 10.1200\/jco.2007.12.5922","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2012.13.7.3501","article-title":"CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls","volume":"13","author":"Yang Y","year":"2012","unstructured":"Yang Y, Zhang F, Wang Y, Liu SC. CHEK2 1100delC variant and breast cancer risk in Caucasians: a meta-analysis based on 25 studies with 29,154 cases and 37,064 controls. Asian Pac J Cancer Prev. 2012, 13:3501-3505. 10.7314\/apjcp.2012.13.7.3501","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-008-0162-7","article-title":"CHEK2 1100delC and male breast cancer in the Netherlands","volume":"116","author":"Wasielewski M","year":"2009","unstructured":"Wasielewski M, den Bakker MA, van den Ouweland A, et al.. CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat. 2009, 116:397-400. 10.1007\/s10549-008-0162-7","journal-title":"Breast Cancer Res Treat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.08.8229","article-title":"CHEK2 mutation and hereditary breast cancer","volume":"25","author":"Narod SA","year":"2007","unstructured":"Narod SA, Lynch HT. CHEK2 mutation and hereditary breast cancer. J Clin Oncol. 2007, 25:6-7. 10.1200\/jco.2006.08.8229","journal-title":"J Clin Oncol"},{"key":"ref8","unstructured":"Genetic\/Familial High-Risk Assessment. Breast, Ovarian, and Pancreatic. (2019). Accessed: April 12, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_bop.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2017.11.002","article-title":"Male breast cancer epidemiology and risk factors","volume":"44","author":"Abdelwahab Yousef AJ","year":"2017","unstructured":"Abdelwahab Yousef AJ. Male breast cancer epidemiology and risk factors. Semin Oncol. 2017, 44:267-272. 10.1053\/j.seminoncol.2017.11.002","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06828-3","article-title":"Male patients with unilateral breast symptoms: an optimal imaging approach","author":"Yoon B","year":"2020","unstructured":"Yoon B, Chae EY, Cha JH, Shin HJ, Choi WJ, Kim HH. Male patients with unilateral breast symptoms: an optimal imaging approach. Eur Radiol. 2020, 10.1007\/s00330-020-06828-3","journal-title":"Eur Radiol"},{"key":"ref11","unstructured":"Breast Cancer Screening and Diagnosis. (2019). Accessed. April 15, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2008.01111.x","article-title":"Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention","volume":"75","author":"Cybulski C","year":"2009","unstructured":"Cybulski C, Huzarski T, Byrski T, et al.. Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention. Clin Genet. 2009, 75:72-78. 10.1111\/j.1399-0004.2008.01111.x","journal-title":"Clin Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.06.3024","article-title":"Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation","volume":"25","author":"Schmid MK","year":"2007","unstructured":"Schmid MK, Tollenaar RA, Kemp SRD, et al.. Breast cancer survival and tumor characteristics in premenopausal women carrying the CHEK2*1100delC germline mutation. J Clin Oncol. 2007, 25:64-69. 10.1200\/jco.2006.06.3024","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4236\/ijcm.2014.517138","article-title":"Male breast cancer clinical features, risk factors, and current diagnostic and therapeutic approaches","volume":"5","author":"Darkeh MHSE","year":"2014","unstructured":"Darkeh MHSE, Azavedo E. Male breast cancer clinical features, risk factors, and current diagnostic and therapeutic approaches. Int J Clin Med. 2014, 5:1068-1086. 10.4236\/ijcm.2014.517138","journal-title":"Int J Clin Med"},{"key":"ref15","unstructured":"Breast Cancer. (2020). Accessed. April 16, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12187","article-title":"Should adjuvant radiation therapy be systematically proposed for male breast cancer? A systematic review","volume":"38","author":"Jardel P","year":"2018","unstructured":"Jardel P, Vignot S, Cutuli B, Creisson A, Vass S, Barranger E, Thariat J. Should adjuvant radiation therapy be systematically proposed for male breast cancer? A systematic review. Anticancer Res. 2018, 38:23-31. 10.21873\/anticanres.12187","journal-title":"Anticancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.3594","article-title":"Increased risk for other cancers in addition to breast cancer for CHEK2*1100delC heterozygotes estimated from the Copenhagen general population study","volume":"34","author":"N\u00e4slund-Koch C","year":"2016","unstructured":"N\u00e4slund-Koch C, Nordestgaard BG, Bojesen SE. Increased risk for other cancers in addition to breast cancer for CHEK2*1100delC heterozygotes estimated from the Copenhagen general population study. J Clin Oncol. 2016, 34:1208-1216. 10.1200\/JCO.2015.63.3594","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32385","article-title":"Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer","volume":"145","author":"Kleiblova P","year":"2019","unstructured":"Kleiblova P, Stolarova L, Krizova K, et al.. Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer. Int J Cancer. 2019, 145:1782-1797. 10.1002\/ijc.32385","journal-title":"Int J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.025","article-title":"Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility","volume":"47","author":"Xiang HP","year":"2011","unstructured":"Xiang HP, Geng XP, Ge WW, Li H. Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibility. Eur J Cancer. 2011, 47:2546-2551. 10.1016\/j.ejca.2011.03.025","journal-title":"Eur J Cancer"},{"key":"ref20","unstructured":"Genetic\/Familial High-Risk Assessment. Colorectal. (2019). Accessed: April 15, 2020: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_colon.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/33599-a-case-of-male-breast-cancer-patient-with-chek21100delc-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:18:25Z","timestamp":1707506305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/33599-a-case-of-male-breast-cancer-patient-with-chek21100delc-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.8972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}